Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4251
eHealth
EHTH
$14.2M
| $52.4K | ﹤0.01% |
73,854
-10,249
| -12% | -$12.4K |
2026 Q2
1 quarter
|
|
4252
Accendra Health
ACH
$11.2M
| $51.1K | ﹤0.01% |
+90,769
| New | +$182K |
2026 Q3
0 quarters
|
|
4253
NIO
NIO
$7.64B
| $50.9K | ﹤0.01% |
14,826
-12,562
| -46% | -$54.7K |
2026 Q1
2 quarters
|
|
4254
Blend Labs
BLND
$255M
| $50.7K | ﹤0.01% |
49,178
-74,974
| -60% | -$117K |
2026 Q2
1 quarter
|
|
4255
Televisa
TV
$2.34B
| $48.7K | ﹤0.01% |
21,350
-6,810
| -24% | -$18.1K |
2025 Q2
5 quarters
|
|
4256
Clene
CLNN
$57.6M
| $48.6K | ﹤0.01% |
+11,920
| New | +$57.2K |
2026 Q3
0 quarters
|
|
4257
Vivid Seats
SEAT
$14.1M
| $48.6K | ﹤0.01% |
+12,583
| New | +$80K |
2026 Q3
0 quarters
|
|
4258
AirSculpt Technologies
AIRS
$53.2M
| $48.5K | ﹤0.01% |
27,578
+9,738
| +55% | +$33.1K |
2025 Q3
4 quarters
|
|
4259
Gaotu Techedu
GOTU
$578M
| $48.5K | ﹤0.01% |
20,107
-5,378
| -21% | -$10.3K |
2024 Q4
7 quarters
|
|
4260
Eve Holding
EVEX
$617M
| $48.2K | ﹤0.01% |
25,000
+9,341
| +60% | +$22.2K |
2025 Q4
3 quarters
|
|
4261
Connect Biopharma Holdings
CNTB
$41.9M
| $47.3K | ﹤0.01% |
+42,972
| New | +$87.8K |
2026 Q3
0 quarters
|
|
4262
Northern Dynasty Minerals
NAK
$340M
| $46.9K | ﹤0.01% |
+34,230
| New | +$54.1K |
2026 Q3
0 quarters
|
|
4263
PUT
JetBlue
JBLU
$1.44B
| $46.1K | ﹤0.01% |
+10,900
| New | +$56.4K |
2026 Q3
0 quarters
|
|
4264
Xerox Holdings Corp Warrants
XRXDW
$10.6M
| $46.1K | ﹤0.01% |
167,087
| – | – |
2026 Q1
2 quarters
|
|
4265
Bicycle Therapeutics
BCYC
$242M
| $44.4K | ﹤0.01% |
+12,074
| New | +$48.8K |
2026 Q3
0 quarters
|
|
4266
Cato Corp
CATO
$45.2M
| $40.4K | ﹤0.01% |
16,883
-31,866
| -65% | -$94.9K |
2025 Q2
5 quarters
|
|
4267
Thryv Holdings
THRY
$43.3M
| $40.2K | ﹤0.01% |
25,578
-14,109
| -36% | -$38.6K |
2026 Q2
1 quarter
|
|
4268
OFS Capital
OFS
$48.6M
| $39.6K | ﹤0.01% |
+10,915
| New | +$39.9K |
2026 Q3
0 quarters
|
|
4269
Seres Therapeutics
MCRB
$14.4M
| $38.6K | ﹤0.01% |
+11,523
| New | +$58.1K |
2026 Q3
0 quarters
|
|
4270
Drilling Tools International
DTI
$60.7M
| $38.5K | ﹤0.01% |
16,622
-955
| -5% | -$2.29K |
2026 Q2
1 quarter
|
|
4271
OPAL Fuels
OPAL
$37.6M
| $38.2K | ﹤0.01% |
+21,850
| New | +$46.4K |
2026 Q3
0 quarters
|
|
4272
SES AI
SES
$215M
| $38K | ﹤0.01% |
+63,266
| New | +$37.3K |
2026 Q3
0 quarters
|
|
4273
Outset Medical
OM
$72.8M
| $38K | ﹤0.01% |
12,652
-10,050
| -44% | -$41K |
2026 Q2
1 quarter
|
|
4274
PUT
Enovix
ENVX
$395M
| $37.7K | ﹤0.01% |
13,000
| – | – |
2024 Q4
7 quarters
|
|
4275
Marker Therapeutics
MRKR
$15M
| $36.9K | ﹤0.01% |
+34,485
| New | +$43.7K |
2026 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.